多发性骨髓瘤中的T细胞参与者:临床综述
Ahmad Al-Jarrad1, Samhar Samer Alouch1, Yogesh Chawla1
1Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Blood and lymphatic cancer : targets and therapy
|March 31, 2025
概括
针对BCMA和GPRC5D的T细胞参与剂在复发性/耐药性多发性髓瘤中显示出高响应率. 进一步的研究旨在提高下一代疗法的疗效和减少副作用.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- T细胞参与剂 (TCEs) 提高T细胞对抗癌症的活性.
- 针对BCMA和GPRC5D的TCE在多发性髓瘤中表现有前途.
研究的目的:
- 审查BCMA和GPRC5D向TCE的临床活性和毒性.
- 讨论多发性骨髓瘤中TCE发展的未来方向.
主要方法:
- 对针对BCMA和GPRC5D的TCE临床试验数据的审查.
- 对响应率,耐用性和安全性配置文件的分析.
主要成果:
- 在复发性/耐药性多发性髓瘤中,TCE单疗实现了超过60%的整体应答率.
- 观察到深度和持久的血液学反应.
- 常见的毒性包括细胞因子释放综合征和感染.
结论:
- 针对BCMA和GPRC5D的TCE在重度预治疗的多发性骨髓瘤患者中有效.
- 目前正在进行的研究重点是为未来的TCE代增强疗效和耐受性.
更多相关视频
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
8.6K
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
6.7K
相关概念视频
T Cell Activation and Clonal Selection
596
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
596
Tumor Immunotherapy
432
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
432
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
